{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have underscored the importance of microRNAs as biomarkers in oncology, and miR‐3142 is emerging as a promising candidate for cervical cancer evaluation. In one investigation, researchers examined the serum expression of miR‐3142 in cohorts of cervical cancer patients versus healthy controls to assess its potential as a non‐invasive diagnostic marker. Their findings suggest that altered levels of miR‐3142 may reflect the presence of malignant processes, thereby offering a novel approach to early detection."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "In addition to its diagnostic utility, the study explored the prognostic implications of miR‐3142 expression. The observed serum expression patterns indicate that miR‐3142 could also serve as a predictor of clinical outcomes in cervical cancer patients, potentially informing treatment decisions and prognosis evaluations. As such, miR‐3142 not only holds promise for early cancer detection but may also provide valuable insights into tumor progression and patient survival."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Qinghua Luo, Hao Wang, Jing Li "}, {"type": "b", "children": [{"type": "t", "text": "Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2018.180925"}], "href": "https://doi.org/10.7754/Clin.Lab.2018.180925"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30969093"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30969093"}]}]}]}